BIOMAT Database Logo BIOMAT Database Logo

Synthesis, biological evaluation and molecular modeling of a novel series of 7-azaindole based tri-heterocyclic compounds as potent CDK2/Cyclin E inhibitors. 2016

Christine B Baltus, and Radek Jorda, and Christophe Marot, and Karel Berka, and Václav Bazgier, and Vladimír Kryštof, and Gildas Prié, and Marie-Claude Viaud-Massuard
UMR 7292 GICC Equipe 4 Innovation Moléculaire et Thérapeutique, Labex SYNORG, University of Tours, Faculty of Pharmacy, 31 Avenue Monge, 37200 Tours, France.

From four molecules, inspired by the structural features of fascaplysin, with an interesting potential to inhibit cyclin-dependent kinases (CDKs), we designed a new series of tri-heterocyclic derivatives based on 1H-pyrrolo[2,3-b]pyridine (7-azaindole) and triazole heterocycles. Using a Huisgen type [3 + 2] cycloaddition as the convergent key step, 24 derivatives were synthesized and their biological activities were evaluated. Comparative molecular field analysis (CoMFA), based on three-dimensional quantitative structure-activity relationship (3D-QSAR) studies, was conducted on a series of 30 compounds from the literature with high to low known inhibitory activity towards CDK2/cyclin E and was validated by a test set of 5 compounds giving satisfactory predictive r(2) value of 0.92. Remarkably, it also gave a good prediction of pIC50 for our tri-heterocyclic series which reinforce the validation of this model for the pIC50 prediction of external set compounds. The most promising compound, 43, showed a micro-molar range inhibitory activity against CDK2/cyclin E and also an antiproliferative and proapoptotic activity against a panel of cancer cell lines.

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006571 Heterocyclic Compounds Cyclic compounds that include atoms other than carbon in their ring structure. Heterocyclic Compound,Compound, Heterocyclic,Compounds, Heterocyclic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Christine B Baltus, and Radek Jorda, and Christophe Marot, and Karel Berka, and Václav Bazgier, and Vladimír Kryštof, and Gildas Prié, and Marie-Claude Viaud-Massuard
Discovering novel 7-azaindole-based series as potent AXL kinase inhibitors.
February 2017, Bioorganic & medicinal chemistry letters,
Christine B Baltus, and Radek Jorda, and Christophe Marot, and Karel Berka, and Václav Bazgier, and Vladimír Kryštof, and Gildas Prié, and Marie-Claude Viaud-Massuard
Synthesis and biological evaluation of novel pteridin-7(8H)-one derivatives as potent CDK2 inhibitors.
May 2023, Bioorganic & medicinal chemistry letters,
Christine B Baltus, and Radek Jorda, and Christophe Marot, and Karel Berka, and Václav Bazgier, and Vladimír Kryštof, and Gildas Prié, and Marie-Claude Viaud-Massuard
Rational Design, Synthesis, and Biological Evaluation of 7-Azaindole Derivatives as Potent Focused Multi-Targeted Kinase Inhibitors.
April 2016, Journal of medicinal chemistry,
Christine B Baltus, and Radek Jorda, and Christophe Marot, and Karel Berka, and Václav Bazgier, and Vladimír Kryštof, and Gildas Prié, and Marie-Claude Viaud-Massuard
A convenient synthesis and molecular modeling study of novel purine and pyrimidine derivatives as CDK2/cyclin A3 inhibitors.
November 2010, Bioorganic & medicinal chemistry,
Christine B Baltus, and Radek Jorda, and Christophe Marot, and Karel Berka, and Václav Bazgier, and Vladimír Kryštof, and Gildas Prié, and Marie-Claude Viaud-Massuard
Discovery of a Novel Series of 7-Azaindole Scaffold Derivatives as PI3K Inhibitors with Potent Activity.
August 2017, ACS medicinal chemistry letters,
Christine B Baltus, and Radek Jorda, and Christophe Marot, and Karel Berka, and Václav Bazgier, and Vladimír Kryštof, and Gildas Prié, and Marie-Claude Viaud-Massuard
Design, synthesis, and molecular modeling of heterocyclic bioisostere as potent PDE4 inhibitors.
April 2018, Archiv der Pharmazie,
Christine B Baltus, and Radek Jorda, and Christophe Marot, and Karel Berka, and Václav Bazgier, and Vladimír Kryštof, and Gildas Prié, and Marie-Claude Viaud-Massuard
Synthesis, biological evaluation, and molecular modeling of berberine derivatives as potent acetylcholinesterase inhibitors.
February 2010, Bioorganic & medicinal chemistry,
Christine B Baltus, and Radek Jorda, and Christophe Marot, and Karel Berka, and Václav Bazgier, and Vladimír Kryštof, and Gildas Prié, and Marie-Claude Viaud-Massuard
Synthesis and biological evaluation of novel 5,6-dihydropyrimido[4,5-f]quinazoline derivatives as potent CDK2 inhibitors.
November 2018, Bioorganic & medicinal chemistry letters,
Christine B Baltus, and Radek Jorda, and Christophe Marot, and Karel Berka, and Václav Bazgier, and Vladimír Kryštof, and Gildas Prié, and Marie-Claude Viaud-Massuard
Design, Synthesis and Biological Evaluation of a Novel Series of Thiadiazole- Based Anticancer Agents as Potent Angiogenesis Inhibitors.
January 2021, Anti-cancer agents in medicinal chemistry,
Christine B Baltus, and Radek Jorda, and Christophe Marot, and Karel Berka, and Václav Bazgier, and Vladimír Kryštof, and Gildas Prié, and Marie-Claude Viaud-Massuard
Design, synthesis, and biological evaluation of novel pyrimidine derivatives as CDK2 inhibitors.
March 2010, European journal of medicinal chemistry,
Copied contents to your clipboard!